- Celularity Inc. (CELU) authorized the issuance of **6,000,000 shares** of Series A Convertible Preferred Stock via unanimous written consent on **October 24, 2025**.  **[1752828_0001493152-25-019839_ex3-1.htm:0]** 
- The company will issue up to **$6,666,667** in stated value of Series A Convertible Preferred Stock, with each share having a stated value of **$1.111111** and purchased at **90% of its stated value**.  **[1752828_0001493152-25-019839_ex10-1.htm:0]** **[1752828_0001493152-25-019839_ex10-3.htm:0]** **[1752828_0001493152-25-019839_ex3-1.htm:1]** 
- The Series A Convertible Preferred Stock carries a dividend rate of **5.0% per annum**, which increases to **18.0% per annum** during a Triggering Event, and has a maturity date of **twelve months** after its initial issuance.  **[1752828_0001493152-25-019839_ex3-1.htm:1]** 
- Key conversion terms include a Floor Price of **$1.60 per share** and a Beneficial Ownership Limitation of **4.99%** of the outstanding Common Stock.  **[1752828_0001493152-25-019839_ex10-1.htm:0]** **[1752828_0001493152-25-019839_ex3-1.htm:1]**

Celularity (CELU)